Washington Examiner logo
The Blaze logo
Boston Herald logo
4 articles
·2M

Joe Biden's Cancer Diagnosis Sparks Controversy and Congressional Scrutiny

Former President Joe Biden's prostate cancer diagnosis raises questions about his health and the timing of its disclosure amid political scrutiny.

Overview

A summary of the key points of this story verified across multiple sources.

Joe Biden's recent diagnosis of aggressive prostate cancer has ignited political controversy, with Republicans alleging a cover-up of his health issues during his presidency. The diagnosis, revealed after a series of negative press reports, has led to renewed congressional inquiries into Biden's mental and physical fitness. Critics, including some former supporters, argue that the Democratic Party ignored signs of Biden's decline. Medical experts suggest that the cancer's progression may have been ongoing for years, raising further questions about transparency and accountability in the Biden administration.

Content generated by AI—learn more or report issue.

Pano Newsletter

Get both sides in 5 minutes with our daily newsletter.

Analysis

Compare how each side frames the story — including which facts they emphasize or leave out.

Analysis unavailable for this viewpoint.

Articles (4)

Compare how different news outlets are covering this story.

Center (0)

No articles found in the Center category

FAQ

Dig deeper on this story with frequently asked questions.

Joe Biden was diagnosed with stage 4 prostate cancer on May 16, 2025, after a small nodule was found in his prostate and further evaluation was conducted.

He was diagnosed with an aggressive form of prostate cancer characterized by a Gleason score of 9 (Grade Group 5) with metastasis to his bones, indicating stage 4 cancer.

The diagnosis sparked controversy because Republicans allege a cover-up of his health issues during his presidency, and critics argue there was a lack of transparency and accountability from the Biden administration regarding his health.

Joe Biden's last known Prostate Specific Antigen (PSA) test was in 2014, and he had not been diagnosed with prostate cancer before May 2025, indicating he had not undergone recent regular screening.

Medical experts note that although his cancer is aggressive and has spread to the bones, it appears to be hormone-sensitive, which allows for effective management. They also suggest the cancer may have been progressing for years before diagnosis.

History

See how this story has evolved over time.

  • This story does not have any previous versions.